Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys

Morin, N and Morissette, M and Gregoire, L and Gomez-Mancilla, B and Gasparini, F and Di Paolo, T (2013) Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys. NEUROPHARMACOLOGY. pp. 216-231.

Item Type: Article
Additional Information: pubid: 47 nvp_institute: NIBR contributor_address: Laval Univ Med Ctr CHUQ, Neurosci Res Unit, Quebec City, PQ G1V 4G2, Canada, Univ Laval, Fac Pharm, Quebec City, PQ, Canada therese.dipaolo@crchul.ulaval.ca; Laval Univ Med Ctr CHUQ, Neurosci Res Unit, Quebec City, PQ G1V 4G2, Canada ; Novartis Inst BioMed Res, Basel, Switzerland ; Laval Univ Med Ctr CHUQ, Neurosci Res Unit, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Quebec City, PQ, Canada; Di Paolo, T; Laval Univ Med Ctr CHUQ, Neurosci Res Unit, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada
Date Deposited: 13 Oct 2015 13:13
Last Modified: 13 Oct 2015 13:13
URI: https://oak.novartis.com/id/eprint/21895

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.